Page 65 - David Ricks News Today

NFLPAs DeMaurice Smith on NFLs leadership in fighting COVID-19 on and off the field February 5, 2021 / 6:01 AM / CBS News In this episode of Facing Forward, Margaret Brennan talks with DeMaurice Smith, NFL Players Association (NFLPA) Executive Director on navigating a health crisis with one the worlds most-watched sports events. After a season of strict COVID protocols and scheduling adjustments, what were some of the lessons the league learned to make it to Super Bowl Sunday COVID-free?...

Eli Lillys Antibody Therapy showed great results after series of clinical trials as its sales went on an upward spree caused by the demand for the...

Eli Lilly CEO David Ricks on treating coronavirus amid threat of new strains January 28, 2021 / 6:37 PM / CBS News In this episode of Facing Forward, Margaret Brennan talks with David Ricks, CEO of Eli Lilly, one of the largest pharmaceutical companies in the world that makes one of the few FDA-approved antibody drugs for COVID-19. In their conversation, Ricks talks about what the drug giant is doing to keep up with the evolving pandemic.  Listen to Highlights On competition in th...

Lilly gains after antibody sales boost fourth-quarter earnings Emma Court, Bloomberg News An Eli Lilly & Co. logo is seen on a box of Humulin brand insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois, U.S., on Monday, Oct. 23, 2017. Eli Lilly is scheduled to release earnings figures on October 24. Photographer: Daniel Acker/Bloomberg , Photographer: Daniel Acker/Bloomberg ​Eli Lilly & Co. rose Friday as sal...

Eli Lilly says monoclonal antibody cocktail cuts hospitalizations by 70% for high-risk COVID-19 patients Karen Weintraub, USA TODAY Replay Video UP NEXT While vaccines may help slow the COVID-19 pandemic over the next months, drug company Eli Lilly announced Tuesday that its treatments can help save lives in the meantime.  The companys drug bamlanivimab was authorized by the U.S. Food and Drug Administration late last year and has been used by 125,000 high-risk patients nati...

Among high-risk patients who received a placebo, 10% were hospitalized, compared to just 2% of those who received the drug cocktail – a 70% drop.

"Everything she does fuses into politics. Shes become unmoored," the exec said.  A financial-communications executive had recommended a conservative-leaning client appear on Bartiromos show "Mornings with Maria," but the client declined, citing the political overhang.  "Shes really pro-Trump, and her show became a political show, not a business show," this person said, adding that it was tricky for business executives to be sandwiched between politicians because the subject matter and questio...

Eli Lilly’s antibody drug was found to significantly reduce the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, the company said Thursday.

First published on With two highly effective coronavirus vaccines now being distributed across the country, the U.S. government’s announcement Thursday to set aside $2.6 billion for purchasing an antibody drug for COVID-19 may have raised a few eyebrows.  After all, the two currently authorized antibody drugs, from Regeneron and Eli Lilly, have not been widely used since the Food and Drug Administration cleared both in November. And the logistical issues that have hindered their launch haven...

Share it The second day of the J.P. Morgan Healthcare Conference didnt bring any billion-dollar acquisitions or high-priced partnerships. But the light slate of news felt a little less existential than might be expected for a meeting that prides itself on market-moving developments. Biotech stock indices continue to do well, boosted by a stretch of dealmaking that closed out 2020. Venture and IPO fundraising hit record highs last year. And the industry is one month removed from the success of c...